UroGen Pharma Ltd
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Other eventsAug 20 →InsidersNo open-market buys. 3 insiders sold $1.4M, 3 of 11 sales on a 10b5-1 plan.→PeersClosest companies: SMMT, ELVN, NUVB→
From the filings
Figures
- Revenue
- $188.7Mlast 12 months
- Net income
- −$97.6Mlast 12 months
- Operating cash flow
- −$165.7Mlast 12 months
- Cash and equivalents
- $79.1Mat the last balance sheet
- Total debt
- $188.7Mat the last balance sheet
- Shares outstanding
- 48.9M shareson issue